Leronlimab increased PD-L1 in patients with triple-negative breast cancer, potentially making cold tumors responsive to ...

An exciting new treatment approach for aggressive breast cancers significantly improves survival rates for patients ...

Samuraciclib improved progression-free survival in HR+ advanced breast cancer patients without TP53 mutations or liver ...

Shorter breastfeeding duration and younger age at first birth are known risk factors for triple negative breast cancer (TNBC) ...

Overall survival (OS) in BRCA -mutated breast cancer improved significantly with the addition of olaparib (Lynparza) to ...

In neighborhoods across America, women face a daunting threat from a federal practice that, although it was outlawed decades ago, continues to negatively impact their health today.

New research indicates that while the residential segregation policy was outlawed decades ago, it still impacts women's health today.